Search

Search results

177 results found

Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated with Treatment Failure in Patients with Inflammatory Bowel Disease.

Saraga, Alessandra, Tina Deyhim, Ajay Gade, Grace Geeganage, Mostafa Soliman, Nathan David Vanshelboym Rothschild, Samantha Zullow, et al. 2026. “Higher Anti-Drug Antibody Levels to Anti-Tumor Necrosis Factor Therapies Are Associated With Treatment Failure in Patients With Inflammatory Bowel Disease.”. Journal of Clinical Medicine 15 (2).

Cutting Through the Clot: Rethinking Venous Thromboembolism Prophylaxis in Plastic Surgery with Aspirin, Direct Oral Anticoagulants, and Low Molecular Weight Heparin.

Zhou, Shannon Y, Jose Foppiani, Molly A Vance, Zeling Yu, Lacey Foster, Dominika Gavlasova, Elan Choudry, et al. 2026. “Cutting Through the Clot: Rethinking Venous Thromboembolism Prophylaxis in Plastic Surgery With Aspirin, Direct Oral Anticoagulants, and Low Molecular Weight Heparin.”. Aesthetic Plastic Surgery 50 (6): 2359-71.

2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Members, Writing Committee, Mark A Creager, Geoffrey D Barnes, Jay Giri, Debabrata Mukherjee, William Schuyler Jones, Allison E Burnett, et al. 2026. “2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.”. Circulation 153 (12): e977-e1051.